Dashboard
Manage Tickers

APTVAptiv PLC

NYSE aptiv.com


$ 67.33 $ -0.78 (-1.14 %)    

Monday, 12-Aug-2024 15:50:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 450.66 $ -1.04 (-0.23 %)
DIA $ 393.40 $ -2.20 (-0.56 %)
SPY $ 532.36 $ -2.26 (-0.42 %)
TLT $ 96.64 $ 0.64 (0.66 %)
GLD $ 228.38 $ 2.26 (1 %)
$ 67.64
$ 68.11
$ 66.80 x 102
$ 67.45 x 100
$ 66.77 - $ 68.11
$ 65.13 - $ 105.78
3,321,227
na
18.29B
$ 1.69
$ 4.96
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-06-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-08-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-07-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-08-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-03-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-04-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 07-31-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-05-2018 02-05-2018 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-03-2017 03-31-2017 10-Q
31 02-06-2017 12-31-2016 10-K
32 11-02-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 02-08-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-09-2015 12-31-2014 10-K
40 10-24-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-aptiv-lowers-price-target-to-100
Barclays Maintains Overweight on Aptiv, Lo...
08/05/2024 23:38:34

Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $105 to $100.

10-consumer-discretionary-stocks-whale-activity-in-todays-session
10 Consumer Discretionary Stocks Whale Act...
08/05/2024 17:35:17

jp-morgan-maintains-overweight-on-aptiv-raises-price-target-to-107
JP Morgan Maintains Overweight on Aptiv, R...
08/05/2024 13:09:59

JP Morgan analyst Ryan Brinkman maintains Aptiv (NYSE:APTV) with a Overweight and raises the price target from $104 to $107.

wells-fargo-maintains-equal-weight-on-aptiv-lowers-price-target-to-78
Wells Fargo Maintains Equal-Weight on Apti...
08/02/2024 18:41:27

Wells Fargo analyst Colin Langan maintains Aptiv (NYSE:APTV) with a Equal-Weight and lowers the price target from $82 to $78.

aptiv--filed-for-mixed-shelf-size-not-disclosed
Aptiv Filed For Mixed Shelf; Size Not Dis...
08/01/2024 20:51:31

S-3ASR

air-products-posts-upbeat-earnings-joins-meta-exact-sciences-shake-shack-clearwater-analytics-and-other-big-stocks-moving-higher-on-thursday
Air Products Posts Upbeat Earnings, Joins ...
08/01/2024 15:42:35

aptiv-lowers-fy24-revenue-outlook-sees-sales-of-2010b-2040b-vs-2103b-estimate-prior-view-2085b-2145b-company-projects-adjusted-eps-of-615-645-vs-603-estimate-prior-view-580-630
Aptiv Lowers FY24 Revenue Outlook: Sees Sa...
08/01/2024 10:54:33

aptiv-reveals-new-5b-authorization-and-3b-accelerated-share-repurchase-program
Aptiv Reveals New $5B Authorization And $3...
08/01/2024 10:49:29

Aptiv announced today that its Board of Directors has authorized a new $5.0 billion share repurchase program. This program will...

aptiv-q2-adj-158-beats-142-estimate-sales-505b-miss-531b-estimate
Aptiv Q2 Adj $1.58 Beats $1.42 Estimate, S...
08/01/2024 10:47:50

Aptiv (NYSE:APTV) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.42 by 11.27 pe...

b-of-a-securities-maintains-buy-on-aptiv-lowers-price-target-to-105
B of A Securities Maintains Buy on Aptiv, ...
07/22/2024 17:08:28

B of A Securities analyst John Murphy maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $115 to $105.

jp-morgan-maintains-overweight-on-aptiv-lowers-price-target-to-104
JP Morgan Maintains Overweight on Aptiv, L...
07/22/2024 14:26:55

JP Morgan analyst Ryan Brinkman maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $113 to $104.

barclays-maintains-overweight-on-aptiv-lowers-price-target-to-105
Barclays Maintains Overweight on Aptiv, Lo...
07/16/2024 15:49:54

Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $110 to $105.

evercore-isi-group-maintains-outperform-on-aptiv-lowers-price-target-to-115
Evercore ISI Group Maintains Outperform on...
07/15/2024 14:34:18

Evercore ISI Group analyst Chris McNally maintains Aptiv (NYSE:APTV) with a Outperform and lowers the price target from $125...

citigroup-maintains-buy-on-aptiv-lowers-price-target-to-108
Citigroup Maintains Buy on Aptiv, Lowers P...
07/12/2024 19:02:36

Citigroup analyst Itay Michaeli maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $128 to $108.

analyst-expectations-for-aptivs-future
Analyst Expectations For Aptiv's Future
07/12/2024 19:00:33

baird-maintains-neutral-on-aptiv-lowers-price-target-to-83
Baird Maintains Neutral on Aptiv, Lowers P...
07/12/2024 15:48:49

Baird analyst David Leiker maintains Aptiv (NYSE:APTV) with a Neutral and lowers the price target from $90 to $83.

goldman-sachs-maintains-buy-on-aptiv-lowers-price-target-to-101
Goldman Sachs Maintains Buy on Aptiv, Lowe...
07/10/2024 15:18:35

Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $118 to $101.

ubs-maintains-buy-on-aptiv-lowers-price-target-to-99
UBS Maintains Buy on Aptiv, Lowers Price T...
07/10/2024 13:28:09

UBS analyst Joseph Spak maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $107 to $99.

oppenheimer-maintains-outperform-on-aptiv-maintains-145-price-target
Oppenheimer Maintains Outperform on Aptiv,...
07/09/2024 15:30:21

Oppenheimer analyst Colin Rusch maintains Aptiv (NYSE:APTV) with a Outperform and maintains $145 price target.

moderna-and-walgreens-boots-alliance-were-among-the-10-biggest-large-cap-losers-last-week-june-23---june-29-are-these-in-your-portfolio
Moderna And Walgreens Boots Alliance Were ...
06/30/2024 18:21:19

10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com,...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION